2024’s ranking of intellectual property law firms; the Unified Patent Court’s first year; gender and race-based gaps in patent applications; AI’s ‘double-edged sword’; EU plans for gene-edited crops patent ban and new Standard Essential Patent rules
Listings are based on recommendations made by clients and peers to FT research partner Statista
New technology is set to radically change role of specialist practitioners
While companies may agree on need for more transparency, questions are raised over draft law’s practicality
Critics of plan include green activists, farmers, biotech start-ups and multinationals
Disparities contribute to income inequalities and influence who receives funding for invention, researchers say
UPC network handled hundreds of cases in first year, for companies and investors seeking multi-jurisdictional rulings
EU court finds chain could not show genuine use of term for poultry products in clash with Irish rival
Cambridge shows us what research institutions need to translate scientific excellence into economic impact
US motorcycle company claims that a ‘motorbike-inspired’ T-shirt sold by the UK retailer rips off its logo
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
A synthesis of biology, data science and sociology — aided by artificial intelligence — is creating a pipeline of innovative treatments
Three important books highlight the technology’s great promise — but warn of the dangers of its misuse without regulation
Federal government moves against Asian tech have brought investment rushing in
Shortlisted entries will appear in our report in December, alongside our ranking of the most innovative law firms
A planned public vote on joining an EU body focused on IP protection has been scrapped
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform
Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
Registering name of dead Colombian drug kingpin would flout ‘fundamental values and moral standards’
Lawsuit sets up rare public clash between two big Wall Street rivals
Report says artists are ‘failing to share’ in Britain’s global success due to gaps in IP and copyright regulations
The generics sector is not getting the boost it needs from government
Companies fear changes over product liabilities will lead to a more litigious environment and lawsuits to gain trade secrets
The justice department’s complaint is bold but faces an uphill struggle
UK Edition
